Global Targeted Drugs for Allergic Diseases Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Targeted Drugs for Allergic Diseases market size will reach 46,165 Million USD in 2025 and is projected to reach 136,657 Million USD by 2032, with a CAGR of 16.77% (2025-2032). Notably, the China Targeted Drugs for Allergic Diseases market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Targeted drugs for allergic diseases are medications designed to address the underlying causes and mechanisms of allergic reactions with precision. Unlike traditional allergy treatments, which primarily alleviate symptoms, targeted drugs aim to specifically target and modulate the immune response involved in allergic reactions. These drugs work by blocking or modifying specific pathways, molecules, or cells involved in the allergic response, resulting in more effective and tailored treatment approaches. Examples of targeted drugs for allergic diseases include antihistamines, which block the action of histamine, corticosteroids that reduce inflammation, leukotriene modifiers that target inflammatory molecules, and immunomodulators that regulate immune system activity. By targeting specific aspects of the immune response, these drugs offer improved symptom relief, reduced side effects, and better overall management of allergic diseases such as asthma, allergic rhinitis, and atopic dermatitis.
The major global suppliers of Targeted Drugs for Allergic Diseases include Sanofi, Novartis, GSK, Amgen, AstraZeneca, Biosion, Pfizer, UCB, Otsuka Pharmaceutical, Roche, Keymed Biosciences, Mabpharm, Genrix Bio, Dragon Boat Pharmaceutical, Jiangsu Hengrui Pharmaceuticals, Sunshine Guojian, Qyuns Therapeutics, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Targeted Drugs for Allergic Diseases. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Targeted Drugs for Allergic Diseases market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Targeted Drugs for Allergic Diseases market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Targeted Drugs for Allergic Diseases industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Targeted Drugs for Allergic Diseases Include:
Sanofi
Novartis
GSK
Amgen
AstraZeneca
Biosion
Pfizer
UCB
Otsuka Pharmaceutical
Roche
Keymed Biosciences
Mabpharm
Genrix Bio
Dragon Boat Pharmaceutical
Jiangsu Hengrui Pharmaceuticals
Sunshine Guojian
Qyuns Therapeutics
Targeted Drugs for Allergic Diseases Product Segment Include:
IL-4R
TSLP
IL-5
JAK
IgE
IL-33
Others
Targeted Drugs for Allergic Diseases Product Application Include:
Atopic Dermatitis
Asthma
Chronic Sinusitis with Nasal Polyps
Chronic Obstructive Pulmonary Disease
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Targeted Drugs for Allergic Diseases Industry PESTEL Analysis
Chapter 3: Global Targeted Drugs for Allergic Diseases Industry Porter's Five Forces Analysis
Chapter 4: Global Targeted Drugs for Allergic Diseases Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Targeted Drugs for Allergic Diseases Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Targeted Drugs for Allergic Diseases Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Targeted Drugs for Allergic Diseases Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Targeted Drugs for Allergic Diseases market size will reach 46,165 Million USD in 2025 and is projected to reach 136,657 Million USD by 2032, with a CAGR of 16.77% (2025-2032). Notably, the China Targeted Drugs for Allergic Diseases market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Targeted drugs for allergic diseases are medications designed to address the underlying causes and mechanisms of allergic reactions with precision. Unlike traditional allergy treatments, which primarily alleviate symptoms, targeted drugs aim to specifically target and modulate the immune response involved in allergic reactions. These drugs work by blocking or modifying specific pathways, molecules, or cells involved in the allergic response, resulting in more effective and tailored treatment approaches. Examples of targeted drugs for allergic diseases include antihistamines, which block the action of histamine, corticosteroids that reduce inflammation, leukotriene modifiers that target inflammatory molecules, and immunomodulators that regulate immune system activity. By targeting specific aspects of the immune response, these drugs offer improved symptom relief, reduced side effects, and better overall management of allergic diseases such as asthma, allergic rhinitis, and atopic dermatitis.
The major global suppliers of Targeted Drugs for Allergic Diseases include Sanofi, Novartis, GSK, Amgen, AstraZeneca, Biosion, Pfizer, UCB, Otsuka Pharmaceutical, Roche, Keymed Biosciences, Mabpharm, Genrix Bio, Dragon Boat Pharmaceutical, Jiangsu Hengrui Pharmaceuticals, Sunshine Guojian, Qyuns Therapeutics, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Targeted Drugs for Allergic Diseases. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Targeted Drugs for Allergic Diseases market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Targeted Drugs for Allergic Diseases market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Targeted Drugs for Allergic Diseases industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Targeted Drugs for Allergic Diseases Include:
Sanofi
Novartis
GSK
Amgen
AstraZeneca
Biosion
Pfizer
UCB
Otsuka Pharmaceutical
Roche
Keymed Biosciences
Mabpharm
Genrix Bio
Dragon Boat Pharmaceutical
Jiangsu Hengrui Pharmaceuticals
Sunshine Guojian
Qyuns Therapeutics
Targeted Drugs for Allergic Diseases Product Segment Include:
IL-4R
TSLP
IL-5
JAK
IgE
IL-33
Others
Targeted Drugs for Allergic Diseases Product Application Include:
Atopic Dermatitis
Asthma
Chronic Sinusitis with Nasal Polyps
Chronic Obstructive Pulmonary Disease
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Targeted Drugs for Allergic Diseases Industry PESTEL Analysis
Chapter 3: Global Targeted Drugs for Allergic Diseases Industry Porter's Five Forces Analysis
Chapter 4: Global Targeted Drugs for Allergic Diseases Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Targeted Drugs for Allergic Diseases Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Targeted Drugs for Allergic Diseases Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Targeted Drugs for Allergic Diseases Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Targeted Drugs for Allergic Diseases Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Targeted Drugs for Allergic Diseases Product by Type
- 1.2.1 IL-4R
- 1.2.2 TSLP
- 1.2.3 IL-5
- 1.2.4 JAK
- 1.2.5 IgE
- 1.2.6 IL-33
- 1.2.7 Others
- 1.3 Targeted Drugs for Allergic Diseases Product by Application
- 1.3.1 Atopic Dermatitis
- 1.3.2 Asthma
- 1.3.3 Chronic Sinusitis with Nasal Polyps
- 1.3.4 Chronic Obstructive Pulmonary Disease
- 1.3.5 Others
- 1.4 Global Targeted Drugs for Allergic Diseases Market Size Analysis (2020-2032)
- 1.5 Targeted Drugs for Allergic Diseases Market Development Status and Trends
- 1.5.1 Targeted Drugs for Allergic Diseases Industry Development Status Analysis
- 1.5.2 Targeted Drugs for Allergic Diseases Industry Development Trends Analysis
- 2 Targeted Drugs for Allergic Diseases Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Targeted Drugs for Allergic Diseases Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Targeted Drugs for Allergic Diseases Market Analysis by Country
- 4.1 Global Targeted Drugs for Allergic Diseases Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Targeted Drugs for Allergic Diseases Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Targeted Drugs for Allergic Diseases Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Targeted Drugs for Allergic Diseases Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Targeted Drugs for Allergic Diseases Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Targeted Drugs for Allergic Diseases Market Revenue and Growth Rate (2020-2032)
- 4.5 China Targeted Drugs for Allergic Diseases Market Revenue and Growth Rate (2020-2032)
- 4.6 France Targeted Drugs for Allergic Diseases Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Targeted Drugs for Allergic Diseases Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Targeted Drugs for Allergic Diseases Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Targeted Drugs for Allergic Diseases Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Targeted Drugs for Allergic Diseases Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Targeted Drugs for Allergic Diseases Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Targeted Drugs for Allergic Diseases Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Targeted Drugs for Allergic Diseases Market Revenue and Growth Rate (2020-2032)
- 4.14 India Targeted Drugs for Allergic Diseases Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Targeted Drugs for Allergic Diseases Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Targeted Drugs for Allergic Diseases Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Targeted Drugs for Allergic Diseases Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Targeted Drugs for Allergic Diseases Market Revenue by Key Suppliers (2021-2025)
- 5.2 Targeted Drugs for Allergic Diseases Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Targeted Drugs for Allergic Diseases Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Targeted Drugs for Allergic Diseases Market Analysis by Type
- 6.1 Global Targeted Drugs for Allergic Diseases Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Targeted Drugs for Allergic Diseases Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Sanofi
- 7.1.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Sanofi Targeted Drugs for Allergic Diseases Product Portfolio
- 7.1.3 Sanofi Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Novartis
- 7.2.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Novartis Targeted Drugs for Allergic Diseases Product Portfolio
- 7.2.3 Novartis Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 GSK
- 7.3.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 GSK Targeted Drugs for Allergic Diseases Product Portfolio
- 7.3.3 GSK Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Amgen
- 7.4.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Amgen Targeted Drugs for Allergic Diseases Product Portfolio
- 7.4.3 Amgen Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 AstraZeneca
- 7.5.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 AstraZeneca Targeted Drugs for Allergic Diseases Product Portfolio
- 7.5.3 AstraZeneca Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Biosion
- 7.6.1 Biosion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Biosion Targeted Drugs for Allergic Diseases Product Portfolio
- 7.6.3 Biosion Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Pfizer
- 7.7.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Pfizer Targeted Drugs for Allergic Diseases Product Portfolio
- 7.7.3 Pfizer Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 UCB
- 7.8.1 UCB Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 UCB Targeted Drugs for Allergic Diseases Product Portfolio
- 7.8.3 UCB Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Otsuka Pharmaceutical
- 7.9.1 Otsuka Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Otsuka Pharmaceutical Targeted Drugs for Allergic Diseases Product Portfolio
- 7.9.3 Otsuka Pharmaceutical Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Roche
- 7.10.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Roche Targeted Drugs for Allergic Diseases Product Portfolio
- 7.10.3 Roche Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Keymed Biosciences
- 7.11.1 Keymed Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Keymed Biosciences Targeted Drugs for Allergic Diseases Product Portfolio
- 7.11.3 Keymed Biosciences Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 Mabpharm
- 7.12.1 Mabpharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Mabpharm Targeted Drugs for Allergic Diseases Product Portfolio
- 7.12.3 Mabpharm Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 Genrix Bio
- 7.13.1 Genrix Bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Genrix Bio Targeted Drugs for Allergic Diseases Product Portfolio
- 7.13.3 Genrix Bio Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.14 Dragon Boat Pharmaceutical
- 7.14.1 Dragon Boat Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 Dragon Boat Pharmaceutical Targeted Drugs for Allergic Diseases Product Portfolio
- 7.14.3 Dragon Boat Pharmaceutical Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.15 Jiangsu Hengrui Pharmaceuticals
- 7.15.1 Jiangsu Hengrui Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.15.2 Jiangsu Hengrui Pharmaceuticals Targeted Drugs for Allergic Diseases Product Portfolio
- 7.15.3 Jiangsu Hengrui Pharmaceuticals Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.16 Sunshine Guojian
- 7.16.1 Sunshine Guojian Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.16.2 Sunshine Guojian Targeted Drugs for Allergic Diseases Product Portfolio
- 7.16.3 Sunshine Guojian Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.17 Qyuns Therapeutics
- 7.17.1 Qyuns Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.17.2 Qyuns Therapeutics Targeted Drugs for Allergic Diseases Product Portfolio
- 7.17.3 Qyuns Therapeutics Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Targeted Drugs for Allergic Diseases Industry Chain Analysis
- 8.2 Targeted Drugs for Allergic Diseases Product Downstream Application Analysis
- 8.2.1 Global Targeted Drugs for Allergic Diseases Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Targeted Drugs for Allergic Diseases Revenue and Forecast by Application (2020-2032)
- 8.3 Targeted Drugs for Allergic Diseases Typical Downstream Customers
- 8.4 Targeted Drugs for Allergic Diseases Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
